pharmBD Inc. is a Montréal-based business development and strategic advisory firm operating at the intersection of life sciences, digital health, and innovation. Founded in 2017 and incorporated in Quebec, the company provides specialized BD services to emerging and growth-stage companies seeking licensing, co-development, and commercial partnership opportunities. At this conference, pharmBD is acting as a partnering representative on behalf of four client companies: Innodem Neurosciences (digital biomarkers & neurology), Reverb Therapeutics (bispecific antibodies targeted therapeutics), Ditch Labs (smoking cessation digital health / health tech), and Synucure Therapeutics (neurodegeneration / Parkinson Disease). pharmBD's CEO, Hélène Moore, is available to facilitate introductions and confidential exploratory discussions on behalf of each client. Areas of interest for partnering include licensing, research collaborations, co-development agreements, and strategic alliances across CNS, neurodegenerative disease, and digital health platforms.